Clayton-Smith J, Donnai 0: Human malformations. In Rimoin DL, Connor JM, Pyeritz E (eds): Emery and Rimoin's Principles and Practice of Medical Genetics, 3rd ed. New York, Churchill Livingstone, 1996
Cliver SP, Goldenberg L, Cutter GR, et al: The efect of cigarette smoking on neonatal anthropometric measurements. Obstet Gynecol 85(4):625, 1995 Cohen LS, Friedman JM, Jeferson JW, et al: A reevaluation of risk of in utero exposure to lithium. JAMA 1(2):146, 1994
Conner SN, Bedell V, Lipsey K, et al: Maternal marijuana use and adverse neonatal outcomes. Obstet GynecoIo128(4):713, 2016
Conover EA, Polifka JE: he art and science of teratogen risk communication.
Am J Med Genet C Semin Med Genet 157(3):227,2011
Cooper WO, Hernandez-Diaz S, Arbogast PG, et al: Major congenital malformation after irst-trimester exposure to ACE inhibitors. N Engl J Med 354(23):2443, 2006
Costei AM, Kozer E, Ho T, et al: Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 156(11): 1129, 2002
Cragan JD, Giboa SM: Including prenatal diagnoses in birth defects monitoring: experience of the Metropolitan Atlanta Congenital Birth Defects Program. Birth Defects Res A Clin Mol Teratol 85(1)20, 2009
Creanga A, Sabel JC, Ko JY, et al: Maternal drug use and its efect on neonates: a population-based study in Washington state. Obstet Gynecol 119(5):924,o2012
Crider KS, Cleves MA, Reefhuis J, et al: Antibacterial medication use during pregnancy and risk of birth defects, National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 163:978,o2009
Crijns HJ, Straus SM, Gispen-de Wied C, et al: Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review. Br J DermatoIo164(2):238,o2011
Cross R, Ling C, Day NP, et al: Revisiting doxycycline in pregnancy and early childhood-time to rebuild its reputation? Expert Opinion Drug Saf 15(3):367,o2016 Dally A: halidomide: was the tragedy preventable? Lancet 351: 1197, 1998 Dashe JS, Sheield JS, Olscher DA, et al: Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecolo100(6):1244, 2002 Dawson AL, Riehle-Colarusso T, Reefhuis J, et al: Maternal exposure to methotrexate and birth defects: a population-based study. Am J Med Genet 164A(9):2212,o2014